Staphylococcal Scalded Skin Syndrome in Neonate.

Case Rep Dermatol Med

Department of Dermatology and Infectiology, Training and Research Unit of Medical Sciences, Felix Houphouët Boigny University of Abidjan, BP 5151, Abidjan 21, Côte d'Ivoire.

Published: July 2015

We described a case of Staphylococcal Scalded Skin Syndrome in infant age of 21 days by discussing clinical and management issues. This newborn presented large erythematous, eroded, and oozing areas covered by epidermal skin flap. The average surface of cutaneous unsticking on admission was 31.35% of body surface area corresponding to lesions of superficial second-degree burns. An important biological inflammatory syndrome including positive C-reactive protein was found. Under treatment, erythroderma decreased within 7 to 10 days and the newborn was completely healed after 3 weeks of followup, with the disappearance of the inflammatory syndrome and total body surface restored. This clinical case report showed that SSSS remains a major dermatological problem in neonates. Therefore, its diagnosis should be made without doubt and its care should start earlier in a neonate emergency unit in order to have good prognosis. And the rigorous "search and destroy" policy based on screening of staff and patients and isolation of identified patients advocated in the United Kingdom should be applied in neonate units in Côte d'Ivoire.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475704PMC
http://dx.doi.org/10.1155/2015/901968DOI Listing

Publication Analysis

Top Keywords

staphylococcal scalded
8
scalded skin
8
skin syndrome
8
body surface
8
inflammatory syndrome
8
syndrome
4
syndrome neonate
4
neonate described
4
described case
4
case staphylococcal
4

Similar Publications

This study evaluated the impact of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) on burn wound with dual-species biofilm. Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S.

View Article and Find Full Text PDF

Multiple crosslinked, self-healing, and shape-adaptable hydrogel laden with pain-relieving chitosan@borneol nanoparticles for infected burn wound healing.

Theranostics

January 2025

Department of Radiology, Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, Shaanxi, China.

Next-generation wound dressings with multiple biological functions hold promise for addressing the complications and pain associated with burn wounds. A hydrogel wound dressing loaded with a pain-relieving drug was developed for treating infected burn wounds. Polyvinyl alcohol chemically grafted with gallic acid (PVA-GA), sodium alginate chemically grafted with 3-aminobenzeneboronic acid (SA-PBA), Zn, and chitosan-coated borneol nanoparticles with anti-inflammatory and pain-relieving activities were combined to afford a nanoparticle-loaded hydrogel with a PVA-GA/Zn/SA-PBA network crosslinked via multiple physicochemical interactions.

View Article and Find Full Text PDF
Article Synopsis
  • An infant girl developed widespread blisters and skin peeling, along with fever and cough, showing signs of growth and developmental delays.
  • Imaging revealed kidney abnormalities, and genetic testing indicated a deletion on chromosome 17 affecting the HNF1B gene.
  • Despite the potential diagnosis of Staphylococcal Scalded Skin Syndrome (SSSS), the child was effectively treated with antibiotics, highlighting an unusual case of 17q12 deletion syndrome with early kidney disease and pre-diabetes.
View Article and Find Full Text PDF

Aim: The aim of this review was to summarise the current knowledge on host-related factors that contribute to the development and severity of staphylococcal scalded skin syndrome (SSSS) in children.

Methods: A comprehensive assessment and analysis of the existing literature on SSSS clinical features, pathogenesis and susceptibility factors.

Results: SSSS is a blistering skin disease caused by circulating exfoliative toxins (ETs) of Staphylococcus aureus (S.

View Article and Find Full Text PDF

Benzothiazole-urea hybrid 8l was found to be a potent anti-bacterial agent against methicillin-resistant Staphylococcus aureus (MRSA2858) (MIC = 0.78 μM, Eur J Med Chem. 2022,236:114333).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!